第 2 節　心臟血管及腎臟藥物

Cardiovascular-renal drugs

• 2.1抗血栓劑Antithrombotic agents
  • 2.1.1血小板凝集抑制劑 Platelet aggregation inhibitors100/7/1
    • 2.1.1.1Acetylsalicylic acid (Aspirin) 製劑89/2/1
    • 2.1.1.2Ticlopidine (原ticlopidine與acetylsalicylic acid合併使用之情況條文修訂)100/7/1
    • 2.1.1.3Tirofiban如 Aggrastat100/7/1
    • 2.1.1.4Abciximab如 ReoPro100/7/1
    • 2.1.1.5Cilostazol如 Pletaal105/5/1
    • 2.1.1.6Clopidogrel如 Plavix101/12/1
    • 2.1.1.7Eptifibatide如 Integrilin100/7/1
    • 2.1.1.8Clopidogrel-acetylsalicylic acid如 CoPlavix101/12/1
    • 2.1.1.9Ticagrelor如 Brilinta102/7/1
    • 2.1.1.10Prasugrel如 Efient107/11/1
  • 2.1.2血栓溶解劑Thrombolytic drugs100/7/1
    • 2.1.2.1rt-PA如 Actilyse Inj、Metalyse
    • 2.1.2.2rt-PA如 Actilyse Inj112/10/1
    • 2.1.2.3刪除101/4/1
  • 2.1.3肝素類Heparin group
    • 2.1.3.1Tinzaparin注射劑如 Innohep100/7/1
    • 2.1.3.2Enoxaparin 注射劑如 Clexane108/2/1
  • 2.1.4其他抗血栓劑 Other antithrombotic agents100/7/1
    • 2.1.4.1Fondaparinux如 Arixtra111/3/1
    • 2.1.4.2Rivaroxaban如 Xarelto112/3/1
    • 2.1.4.3Apixaban如 Eliquis111/2/1
    • 2.1.4.4Edoxaban如 Lixiana111/2/1
  • 2.1.5直接凝血酶抑制劑(Direct thrombin inhibitors)如 Pradaxa112/3/1
• 2.2血管擴張劑 Vasodilators
  • 2.2.1(刪除)101/9/1
  • 2.2.2Nimodipine inj如 Nimotop93/2/1
  • 2.2.3Papaverine inj
• 2.3血管收縮劑 Vasoconstrictors
  • 2.3.1Sumatriptan succinate如 Imigran108/5/1
• 2.4泌尿道疾患治療藥物 Agents used to treat urological disorders
  • 2.4.1Alprostadil86/9/1
  • 2.4.2Potassium citrate如 Urocit-K tab
  • 2.4.3Pentosan Polysulfate Sodium如 Elmiron Cap92/12/1
• 2.5(刪除)100/7/1
• 2.6降血脂藥物 Drugs used for dyslipidemia
  • 2.6.1全民健康保險降血脂藥物給付規定表115/9/1
  • 2.6.2Ezetimibe115/9/1
  • 2.6.3含ezetimibe及statin類之複方製劑115/9/1
  • 2.6.4PCSK9 血脂調節劑
    • 2.6.4.1Evolocumab如 Repatha114/9/1
    • 2.6.4.2Alirocumab如 Praluent114/9/1
• 2.7乙型擬交感神經阻斷劑Beta blocking agents如 Betaloc ZOK 25mg93/5/1
• 2.8其他 Miscellaneous
  • 2.8.1腦循環改善劑、腦代謝改善劑及血球流變改善劑87/4/1
  • 2.8.2肺動脈高血壓治療劑114/6/1
    • 2.8.2.1Iloprost如 Ventavis、Ilomedin-20100/4/1
    • 2.8.2.2Sildenafil如 Revatio102/8/1
    • 2.8.2.3Ambrisentan如 Volibris107/12/1
    • 2.8.2.4Riociguat如 Adempas104/6/1
    • 2.8.2.5Bosentan如 Tracleer104/8/1
    • 2.8.2.6Macitentan如 Opsumit115/5/1
    • 2.8.2.7Selexipag如 UPTRAVI114/6/1
    • 2.8.2.8Treprostinil如 Remodulin inj.、Tyvaso113/1/1
    • 2.8.2.9Tadalafil如 Adcirca114/6/1
    • 2.8.2.10含macitentan及tadalafil之複方製劑如 Opsynvi115/5/1
    • 2.8.2.11Sotatercept如 Winrevair115/6/1
• 2.9利尿劑 Diuretics100/1/1
  • 2.9.1Eplerenone如 Inspra104/12/1
  • 2.9.2Amiloride單方口服製劑109/9/1
  • 2.9.3Furosemide口服液劑如 Fumide oral solution110/7/1
• 2.10抗心律不整劑Antiarrhythmics112/12/1
  • 2.10.1Dronedarone如 Multaq112/12/1
• 2.11抗痛風劑 Antigout agents
  • 2.11.1Febuxostat如 Feburic108/12/1
  • 2.11.2含allopurinol成分製劑105/2/1
• 2.12Ivabradine如 Coralan106/10/1
• 2.13Tolvaptan109/10/1
  • 2.13.1Tolvaptan如 Samsca109/3/1
  • 2.13.2Tolvaptan如 Jinarc109/10/1
• 2.14Sacubitril+Valsartan如 Entresto111/5/1
• 2.15Digoxin口服液劑如 Cardiacin elixir110/1/1
• 2.16Dapagliflozin如 Forxiga、Jardiance 10mg114/3/1
• 2.17Tafamidis如 Vyndamax113/2/1
• 2.18Captopril內服液劑如 Cen-Capto Oral Solution114/8/1
• 2.19Mavacamten如 Camzyos115/4/1